FDA Approves 18-Month Shelf Life For TAXUS(R) Stent System
Fri, 19 Jan 2007 08:00 AM EST
... Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved extending the shelf life of its TAXUS(R) Express(2)(TM) paclitaxel-eluting coronary stent system in the United States to 18 months from the current shelf life of 12 months. [click link for full article] ...
Related Topics
- Methyltestosterone
- Immune System
- Digestive System
- Endocrine System
- Health System
- Edwards syndrome
- Critical Care
- Trauma
- Mammography
- Nutrition
- Life Table Analysis System
- Nutrition & Physical Acitvity Surveys & Monitoring Systems
- Angioplasty
- Dental Health
- Amoxicillin
- Leuprolide Depot Injection
- Death And Dying
- Child Dental Health
- Colorectal Cancer
- Tacrolimus ointment

Not Signed In -


